Asahi Kasai America, Inc. profile

Transformations in Drug Development for Cell and Gene Therapies

In discussions at INTERPHEX 2025, company representatives seized upon several common themes, most notably safety, sustainability, and the increasing utility of automation.

End-to-end regulatory CDMO solutions: development, manufacturing, and approval (May 2025)

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Innovations in linking rational design

Accelerating clinical development: modern tools in process chemistry

Companies Reveal Their Next Moves in Manufacturing

Related Content

Patrick Lavery

Transformations in Drug Development for Cell and Gene Therapies

In discussions at INTERPHEX 2025, company representatives seized upon several common themes, most notably safety, sustainability, and the increasing utility of automation.

End-to-end regulatory CDMO solutions: development, manufacturing, and approval (May 2025)

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang